Cargando…
Evaluating the Effectiveness of Neoadjuvant Chemotherapy in Reducing Mastectomy for Women With Breast Cancer
BACKGROUND: Neoadjuvant chemotherapy in breast cancer reduced mastectomy rates by 7% to 13% in randomized trials. However, the differential effects for women with different stages, receptor subtypes, and ages are unknown. We compared mastectomy rates in women who did vs did not receive neoadjuvant c...
Autores principales: | Mohiuddin, Jahan J., Deal, Allison M., Lund, Jennifer L., Carey, Lisa A., Baker, Brock R., Zagar, Timothy M., Jones, Ellen L., Marks, Lawrence B., Chen, Ronald C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649828/ https://www.ncbi.nlm.nih.gov/pubmed/31360830 http://dx.doi.org/10.1093/jncics/pkx004 |
Ejemplares similares
-
Team Work: Mastectomy, Reconstruction, and Radiation
por: Kaidar-Person, Orit, et al.
Publicado: (2017) -
Abstract 11. The Effect of Neoadjuvant Chemotherapy Compared to Adjuvant Chemotherapy in Nipple-Sparing Mastectomy
por: Frey, Jordan D., et al.
Publicado: (2017) -
Surgical Outcomes for Mastectomy Patients Receiving Neoadjuvant Chemotherapy: A Propensity-Matched Analysis
por: Bowen, Megan E., et al.
Publicado: (2017) -
Oncological safety of nipple-sparing mastectomy after neoadjuvant chemotherapy: a systematic review
por: NISSEN, LEONARDO, et al.
Publicado: (2023) -
Breast-conserving surgery versus mastectomy for treatment of breast cancer after neoadjuvant chemotherapy
por: Song, Yu-Chun, et al.
Publicado: (2023)